1. Home
  2. MDGL vs CADE Comparison

MDGL vs CADE Comparison

Compare MDGL & CADE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • CADE
  • Stock Information
  • Founded
  • MDGL 2011
  • CADE 1876
  • Country
  • MDGL United States
  • CADE United States
  • Employees
  • MDGL N/A
  • CADE N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • CADE Major Banks
  • Sector
  • MDGL Health Care
  • CADE Finance
  • Exchange
  • MDGL Nasdaq
  • CADE Nasdaq
  • Market Cap
  • MDGL 9.6B
  • CADE 7.0B
  • IPO Year
  • MDGL N/A
  • CADE N/A
  • Fundamental
  • Price
  • MDGL $423.61
  • CADE $37.98
  • Analyst Decision
  • MDGL Strong Buy
  • CADE Buy
  • Analyst Count
  • MDGL 12
  • CADE 11
  • Target Price
  • MDGL $521.09
  • CADE $40.91
  • AVG Volume (30 Days)
  • MDGL 270.6K
  • CADE 2.8M
  • Earning Date
  • MDGL 11-04-2025
  • CADE 10-20-2025
  • Dividend Yield
  • MDGL N/A
  • CADE 3.01%
  • EPS Growth
  • MDGL N/A
  • CADE N/A
  • EPS
  • MDGL N/A
  • CADE 2.77
  • Revenue
  • MDGL $515,547,000.00
  • CADE $1,794,761,000.00
  • Revenue This Year
  • MDGL $394.38
  • CADE $17.38
  • Revenue Next Year
  • MDGL $64.73
  • CADE $11.03
  • P/E Ratio
  • MDGL N/A
  • CADE $13.17
  • Revenue Growth
  • MDGL 3421.98
  • CADE 41.19
  • 52 Week Low
  • MDGL $201.22
  • CADE $25.22
  • 52 Week High
  • MDGL $463.63
  • CADE $40.23
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 46.94
  • CADE 53.59
  • Support Level
  • MDGL $413.82
  • CADE $35.16
  • Resistance Level
  • MDGL $428.69
  • CADE $37.43
  • Average True Range (ATR)
  • MDGL 15.56
  • CADE 1.24
  • MACD
  • MDGL -3.55
  • CADE -0.18
  • Stochastic Oscillator
  • MDGL 26.32
  • CADE 58.49

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

Share on Social Networks: